Perfinity Biosciences, Inc. - Strategic SWOT Analysis Review by GlobalData

VIEWS: 17 PAGES: 17

More Info
									                    Perfinity Biosciences, Inc. - Strategic SWOT Analysis Review
        Reference Code: GDME6406SA                                                                                           Publication Date: JAN 2013

          3000 Kent Avenue                                   Phone             +1 765 7751026                   Revenue         NA
          West Lafayette, IN                                 Fax               +1 765 7751020                   Net Profit      NA
          47906                                              Website           www.perfinity.com                Employees       NA
          United States                                      Exchange                                           Industry        Medical Equipment

       Company Overview
       Perfinity Biosciences, Inc. (Perfinity) formerly known as Quadraspec, Inc. is a diagnostic company engaged in the development,
       manufacture and supply of products that automate the protein separations and mass spec in sample preparation. Perfinity is also
       engaged in the development of in-vitro diagnostic products for the laboratory, clinical, research and life sciences markets. Its
       products are used in mass Spec Sample Preperation, assay development, protein purification, drug development biomarker
       identification and screening during the pre-clinical/clinical development/in clinical diagnostics.
       Key Executives                                                             SWOT Analysis
                     Name                                Title                     Perfinity Biosciences, Inc., SWOT Analysis
         Robert H Ellis                    Director                                Strengths                            Weaknesses
         Steve Plump                       Chief Executive Officer
                                                                                   Partnership with Antech              Reliance on the U.S. Region
        Source: Company Website, Primary and Secondary Research,
                                                                                   Diagnostics
        GlobalData                                                                                                      Contract Manufacturing-
                                                                                   SDI Label-free Detection             Medivative Technologies
        Key Competitors                                                            Technology
         Genzyme Oncology
         Avrio Biopharmaceuticals LLC                                              Opportunities                        Threats
         Neuronautics, Inc.                                                        Aging U.S. Population                Product Liability Claims
         Clinical Research Advantage, Inc.
                                                                                   Recognition                          Stringent Government
        Gen-Probe Incorporated
        Source: Company Website, Primary and Secondary Research,
                                                                                                                        Regulations
        GlobalData

                                                                                  Source: Company Website, Primary and Secondary Research, GlobalData




Perfinity Biosciences, Inc. - Strategic SWOT Analysis Review                                                                     Reference Code: GDME6406SA
Source : www.globalcompanyintelligence.com                                                                                                              Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       Perfinity Biosciences, Inc. - Key Facts ............................................................................................................................................... 4
       Perfinity Biosciences, Inc. - Key Employees....................................................................................................................................... 5
       Perfinity Biosciences, Inc. - Major Products and Services .................................................................................................................. 6
       Perfinity Biosciences, Inc. - History .................................................................................................................................................... 7
       Perfinity Biosciences, Inc. - Locations And Subsidiaries .................................................................................................................... 8
          Head Office ..................................................................................................................................................................................... 8
       Section 2 – Company Analysis ........................................................................................................................................................... 9
       Perfinity Biosciences, Inc. - Business Description .............................................................................................................................. 9
       Perfinity Biosciences, Inc. - SWOT Analysis .................................................................................................................................... 10
          SWOT Analysis - Overview........................................................................................................................................................... 10
          Perfinity Biosciences, Inc. - Strengths........................................................................................................................................... 10
             Strength - Partnership with Antech Diagnostics ........................................................................................................................ 10
             Strength - SDI Label-free Detection Technology ....................................................................................................................... 10
          Perfinity Biosciences, Inc. - Weaknesses ..................................................................................................................................... 10
             Weakness - Reliance on the U.S. Region ................................................................................................................................. 10
             Weakness - Contract Manufacturing- Medivative Technologies ................................................................................................ 11
          Perfinity Biosciences, Inc. - Opportunities..................................................................................................................................... 11
             Opportunity - Aging U.S. Population.......................................................................................................................................... 11
             Opportunity - Recognition.......................................................................................................................................................... 11
             Opportunity - Growth In-vitro Diagnostics Market ...................................................................................................................... 11
             Opportunity - Strategic Agreements .......................................................................................................................................... 11
          Perfinity Biosciences, Inc. - Threats .............................................................................................................................................. 12
             Threat - Product Liability Claims ............................................................................................................................................... 12
             Threat - Stringent Government Regulations .............................................................................................................................. 12
             Threat - Competition and Technological Change ...................................................................................................................... 12
       Perfinity Biosciences, Inc. - Key Competitors ................................................................................................................................... 13
       Section 3 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 14
          Perfinity Biosciences, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 ..................................................................... 14
          Perfinity Biosciences, Inc., Medical Equipment, Deals By Type, 2007 to YTD 2013 .................................................................... 15
       Perfinity Biosciences, Inc., Recent Deals Summary ......................................................................................................................... 16
       Section 4 – Appendix ....................................................................................................................................................................... 17
          Methodolo
								
To top